Integrated Research (IRI) Stock Price, News & Analysis

Company Overview

Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications. It also provides testing, maintenance, and professional services; and software as a service solution. The company offers its products in various countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, as well as through channel-driven distribution networks internationally. It serves banks, credit card companies, telecommunications carriers, technology companies, service providers, and manufacturers. Integrated Research Limited was incorporated in 1988 and is based in North Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 217,538 shs
• Average Volume: N/A
• Market Capitalization: A$78.92 million
• P/E Ratio: 2.86
• Dividend Yield: 4.49%
• Price Target: N/A
• Consensus Rating: N/A

IRI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Integrated Research own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated Research investors own include Accent Group (AX1), Cochlear (COH), CSL (CSL), Corporate Travel Management (CTD), Mineral Resources (MIN), NIB (NHF) and ResMed (RMD).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: N/A
• Current Symbol: ASX:IRI
• CIK: N/A
• Web: www.ir.com
• Phone: 61 2 9966 1066
• Fax: N/A
• Employees: 142
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$0.15
• Trailing P/E Ratio: 2.86
• Forward P/E Ratio: N/A
• P/E Growth: 1
• Net Income: A$27.13 million
• Net Margins: 32.57%
• Pretax Margin: N/A
• Return on Equity: 34.02%
• Return on Assets: 15.53%

Debt

• Debt-to-Equity Ratio: 1.94
• Current Ratio: 3.12
• Quick Ratio: 2.01

Sales & Book Value

• Annual Sales: A$83.29 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 72.50
• Book Value: A$0.51 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 177,350,000
• Free Float: N/A
• Market Cap: A$78.92 million
• Optionable: Not Optionable
• Beta: 1.39